Purchases and Sales Made in Q4 2022 in Viridian Therapeutics, Inc.\De (VRDN)
This table provides information about the institutional ownership of Viridian Therapeutics, Inc.\De (VRDN) during Q4 2022. The information is specifically focused on institutions that hold shares of Viridian Therapeutics, Inc.\DE.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2023
Q4 2022
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-15.4K- 18.82% |
$289K - $458K
|
66.5K
$1.34M
|
|
Feb 14, 2023
Q4 2022
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-21.2K- 40.33% |
$399K - $631K
|
31.4K
$634K
|
|
Feb 14, 2023
Q4 2022
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-26.6K- 9.28% |
$500K - $792K
|
260K
$5.25M
|
|
Feb 13, 2023
Q4 2022
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-29.8K- 13.28% |
$559K - $886K
|
195K
$3.93M
|
|
Feb 14, 2023
Q4 2022
|
Pura Vida Investments, LLC
New York, NY |
SELL
|
- |
-40K- 53.33% |
$751K - $1.19M
|
35K
$707K
|
|
Feb 14, 2023
Q4 2022
|
Polar Asset Management Partners Inc.
Toronto, A6 |
SELL
|
- |
-106K- 34.17% |
$1.99M - $3.16M
|
205K
$4.13M
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-126K- 34.09% |
$2.37M - $3.75M
|
244K
$4.92M
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-126K- 34.09% |
$2.37M - $3.75M
|
244K
$4.92M
|
|
Feb 14, 2023
Q4 2022
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-143K- 75.65% |
$2.69M - $4.26M
|
46.1K
$932K
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-158K- 11.63% |
$2.97M - $4.71M
|
1.2M
$24.3M
|
|
Feb 14, 2023
Q4 2022
|
Tcg Crossover Management, LLC
Palo Alto, CA |
SELL
|
- |
-180K- 15.5% |
$3.39M - $5.36M
|
984K
$19.9M
|
|
Feb 14, 2023
Q4 2022
|
5 Am Venture Management, LLC
San Francisco, CA |
SELL
|
- |
-185K- 38.13% |
$3.47M - $5.5M
|
300K
$6.06M
|
|
Feb 14, 2023
Q4 2022
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-199K- 10.11% |
$3.74M - $5.92M
|
1.77M
$35.8M
|
|
Feb 14, 2023
Q4 2022
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-210K- 16.03% |
$3.94M - $6.25M
|
1.1M
$22.2M
|
|
Feb 14, 2023
Q4 2022
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-290K- 46.18% |
$5.45M - $8.63M
|
338K
$6.83M
|
|
Feb 14, 2023
Q4 2022
|
Ghost Tree Capital, LLC
New York, NY |
SELL
|
- |
-370K- 69.16% |
$6.95M - $11M
|
165K
$3.33M
|
|
Feb 14, 2023
Q4 2022
|
Bvf Inc
San Francisco, CA |
SELL
|
- |
-503K- 28.87% |
$9.44M - $15M
|
1.24M
$25M
|
|
Feb 13, 2023
Q4 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-554K- 84.81% |
$10.4M - $16.5M
|
99.3K
$2.01M
|
|
Feb 14, 2023
Q4 2022
|
Commodore Capital LP
New York, NY |
SELL
|
- |
-676K- 25.08% |
$12.7M - $20.1M
|
2.02M
$40.8M
|